Navigation Links
ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Date:8/7/2008

Positive Results to Date Drive Decision to Expand its Proprietary

Therapeutic Pipeline

ZURICH, Switzerland, Aug. 7 /PRNewswire/ -- ESBATech AG, a leading developer of antibody fragment therapeutics, today announced that the company has raised an additional CHF 23M (USD 22M, EUR 14M) in an extended Series B venture round to expand its development pipeline. A global syndicate of current investors participated in this round including SV Life Sciences, Clarus Ventures, HBM BioVentures, HBM BioCapital, Novartis Bioventures, BioMedinvest and VI Partners.

This funding builds on the company's CHF 50M (USD 49M, EUR 31M) Series B round, which closed in August 2006 and has enabled the company to move its lead molecule, ESBA105, into clinical trials. ESBA105 is a single-chain antibody fragment directed against TNF-alpha and is developed in ophthalmic and additional inflammatory indications.

Dominik Escher, Ph.D., Chief Executive Officer of ESBATech AG, commented, "We are delighted to announce the expansion of our proprietary pipeline with this additional financing. This includes building broad franchises in ophthalmology, rheumatology and respiratory diseases for ESBA105 and additional antibody fragments. Since the announcement of the Series B financing in August 2006, ESBATech has made significant progress in R&D, including the demonstration in animal models that high concentrations of ESBA105 can be achieved in all segments of the eye with topical delivery via eye drops. Furthermore, we have advanced our anti-VEGF program to selection of a development candidate, ESBA903, a single-chain antibody that shows very high potency, stability and solubility, and will be developed for ophthalmic indications. Just like ESBA105, this antibody fragment will be delivered via eye drops and thus represents a true alternative to the current intra-vitreal injections of marketed anti-VEGF inhibitors."

Martin Gertsch, Chief Financ
'/>"/>

SOURCE ESBATech AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ESBATechs Lead Antibody Fragment Enters Clinical Development for Ophthalmic Indications
2. Celator Pharmaceuticals Raises Series C Financing in Excess of $22.5 Million
3. Light Sciences Oncology Raises $40.1 Million in Series C Financing
4. Romark Laboratories Raises $18 Million in Institutional Financing
5. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
6. EntreMed Raises $20 Million to Support Clinical Development Program
7. Globus Medical Raises $110 Million in Series E Financing Round
8. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
9. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
10. Journal of Antimicrobial Chemotherapy Paper Supports Additional Role for Cethromycin as Potential Treatment for Infections Caused by Community- Associated Methicillin Resistant Staphylococcus Aureus (CA-MRSA)
11. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 For its ... California , Art,s-Way Scientific has earned a ... With competition in over 30 categories, MBI,s contest ... MBI members, which include building manufacturers, dealers, and product ... an excellent example the capability of our team," said ...
(Date:7/31/2014)... LONDON , July 31, 2014 ... for the medical industries, announced today the incorporation of genae UK ... United Kingdom has one of the largest medical device ... in 2012 and it is projected to increase by a CAGR ... billion in 2012, equal to 9.5% of GDP. Despite recessionary pressures, ...
(Date:7/31/2014)... NEW YORK , July 31, 2014 /PRNewswire-USNewswire/ ... of discovering and developing better, faster and affordable ... as Senior Vice President, External Affairs. Mr. ... served as Head of Major Donor Relations for ... Fund). In his role, Mr. Brock will guide ...
Breaking Medicine Technology:Art's Way Scientific Earns Prestigious Modular Building Institute Award 2Art's Way Scientific Earns Prestigious Modular Building Institute Award 3Art's Way Scientific Earns Prestigious Modular Building Institute Award 4genae Opens Offices in London 2TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2
... 15 The U.S. Food and Drug Administration (FDA), ... Justice (USDOJ), today announced that Forest Pharmaceuticals, Inc. entered ... responsibility for criminal actions including distribution of an unapproved ... of an FDA inspection. (Logo:   ...
... 15 New England Biolabs (NEB) has announced ... of $1.22 million to fund the research and ... (Logo: http://photos.prnewswire.com/prnh/20090921/NE79207LOGO-b) (Logo: http://www.newscom.com/cgi-bin/prnh/20090921/NE79207LOGO-b) ... developing tools that advance epigenetics research and discovery, ...
Cached Medicine Technology:Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 2Forest Pharmaceuticals Agrees to Guilty Plea for Violating FDA Laws 3New England Biolabs Receives Award to Develop Novel Enzymatic Reagents for Epigenetic Studies 2
(Date:7/31/2014)... 31, 2014 (HealthDay News) -- Many black women put ... new research. It,s estimated by the U.S. Centers ... five black women in the United States are overweight ... entirely to avoid having to have their hair restyled ... study authors said. However, the researchers also noted a ...
(Date:7/31/2014)... published today in Genes & Development , ... Centre,s DNA Replication group, in collaboration with Brookhaven ... mechanisms involved in the enzyme that governs DNA ... system using synthetic, chemical and structural biology approaches, ... in duplicating genetic information embraces DNA through a ...
(Date:7/31/2014)... LDM Global ( http://www.ldmglobal.com ) announces ... is simplified and predictable with fixed fees across the ... leading international provider of legal discovery management services for ... glaringly apparent that both the courts and legal counsel ... the complex pricing structure that plagues the litigation support ...
(Date:7/31/2014)... 2014 The Alaska Center for ... new dentist Dr. Jonathan Oudin, DDS, who will begin ... in Barrow, Alaska, for three years. According to Teresa ... Dr. Oudin to help take on new patients. , ... continue growing and serving the greater Anchorage metro community," ...
(Date:7/31/2014)... July 31, 2014 (HealthDay News) -- Transplant surgeons ... red flags for burnout, a new study suggests. ... the study reported having a low sense of ... to feeling emotionally exhausted, researchers found. "Burnout ... like transplantation," study co-author Dr. Marwan Abouljoud, director ...
Breaking Medicine News(10 mins):Health News:Hairdo Trumps Exercise for Many Black Women, Study Finds 2Health News:Molecular gate that could keep cancer cells locked up 2Health News:LDM Global Announces Predictable Simple Fixed-Fee Pricing 2Health News:Dr. Jonathan Oudin to Join Alaska Center for Dentistry at Wasilla Location 2Health News:Burnout Common Among Transplant Surgeons, Study Reveals 2
... , MONDAY, Nov. 29 (HealthDay News) -- Genetics influence a ... have the greatest impact in the summer, the results of ... to maintain health and for strong bones, is naturally made ... not contain vitamin D unless it,s added by fortification. ...
... Children and teens who are overexposed to antibacterial soaps that ... hay fever and other allergies, a finding that suggests that ... The study also found that exposure to higher levels ... immune system. Triclosan is an antimicrobial agent widely used ...
... November 2010 Reduced male fertility may be making it ... low birth rates in many countries, reveals a new European ... 10% of couples worldwide are infertile, contributing to the growing ... (IVF) for which Robert G. Edwards won the Nobel Prize ...
... In a first-of-its-kind study to measure the impact of ... care unit, researchers at the University of Maryland School ... physicians and other health care professionals can enhance patient ... The results of the study have been released ...
... of people infected with HIV/AIDS in sub-Saharan Africa is ... the end of the decade, forcing African nations to ... of lifesaving antiretroviral therapy (ART), says a new report ... a renewed emphasis on reducing the rate of new ...
... A UCSF research collaboration with GE Healthcare has produced the ... to rapidly assess the presence and aggressiveness of prostate tumors ... is the first time researchers have used this technology to ... a revolutionary approach to assessing the precise outlines of a ...
Cached Medicine News:Health News:Too Much Hygiene May Affect Immune System, Study Suggests 2Health News:Male reproductive problems may add to falling fertility rates 2Health News:More lives saved with 24/7 enhanced staffing in medical ICU 2Health News:More lives saved with 24/7 enhanced staffing in medical ICU 3Health News:More lives saved with 24/7 enhanced staffing in medical ICU 4Health News:Number of HIV/AIDS cases in sub-Saharan Africa expected to greatly outpace resources 2Health News:Number of HIV/AIDS cases in sub-Saharan Africa expected to greatly outpace resources 3Health News:New prostate cancer imaging shows real-time tumor metabolism 2Health News:New prostate cancer imaging shows real-time tumor metabolism 3Health News:New prostate cancer imaging shows real-time tumor metabolism 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: